Publications
- Benzothiazolyl ureas are low micromolar and uncompetitive inhibitors of 17β-HSD10 with implications to Alzheimer's disease treatment2020 | Publication without faculty affiliation
- Novel benzothiazole-based ureas as 17 beta-HSD10 inhibitors, a potential Alzheimer's disease treatment2019 | Publication without faculty affiliation
- 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders2018 | First Faculty of Medicine
- Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17 beta-HSD10 modulators for Alzheimer's disease treatment2016 | Publication without faculty affiliation
- Benzothiazoles - scaffold of interest for CNS targeted drugs2015 | Faculty of Pharmacy in Hradec Králové
- Benzothiazolyl urea derivatives, process of their preparation and their usePublication without faculty affiliation
- Arylbenzothiazolylurea derivatives, preparing and using themPublication without faculty affiliation
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | First Faculty of Medicine
- Small-molecule inhibitors of cyclophilin D as potential therapeutics in mitochondria-related diseases2022 | Publication without faculty affiliation
- Alzheimerova nemoc2020 | Faculty of Medicine in Hradec Králové
Loading network view...